These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 32435805)

  • 1. Effect of Delaying Treatment on Efficacy of Ciprofloxacin and Levofloxacin in the African Green Monkey Model of Pneumonic Plague.
    Campbell JL; Fay MP; Lanning LL; Hewitt JA
    Clin Infect Dis; 2020 May; 70(70 Suppl 1):S60-S65. PubMed ID: 32435805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The African Green Monkey Model of Pneumonic Plague and US Food and Drug Administration Approval of Antimicrobials Under the Animal Rule.
    Hewitt JA; Lanning LL; Campbell JL
    Clin Infect Dis; 2020 May; 70(70 Suppl 1):S51-S59. PubMed ID: 32435803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levofloxacin cures experimental pneumonic plague in African green monkeys.
    Layton RC; Mega W; McDonald JD; Brasel TL; Barr EB; Gigliotti AP; Koster F
    PLoS Negl Trop Dis; 2011 Feb; 5(2):e959. PubMed ID: 21347450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gepotidacin is efficacious in a nonhuman primate model of pneumonic plague.
    Jakielaszek C; Hossain M; Qian L; Fishman C; Widdowson K; Hilliard JJ; Mannino F; Raychaudhuri A; Carniel E; Demons S; Heine HS; Hershfield J; Russo R; Mega WM; Revelli D; O'Dwyer K
    Sci Transl Med; 2022 Jun; 14(647):eabg1787. PubMed ID: 35648812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary pneumonic plague in the African Green monkey as a model for treatment efficacy evaluation.
    Layton RC; Brasel T; Gigliotti A; Barr E; Storch S; Myers L; Hobbs C; Koster F
    J Med Primatol; 2011 Feb; 40(1):6-17. PubMed ID: 20722770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cethromycin-mediated protection against the plague pathogen Yersinia pestis in a rat model of infection and comparison with levofloxacin.
    Rosenzweig JA; Brackman SM; Kirtley ML; Sha J; Erova TE; Yeager LA; Peterson JW; Xu ZQ; Chopra AK
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5034-42. PubMed ID: 21859946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plague Gives Surprises in the Second Decade of the Twenty-First Century.
    Butler T
    Am J Trop Med Hyg; 2023 Nov; 109(5):985-988. PubMed ID: 37748767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lack of levofloxacin and moxyfloxacin efficacy in experimental plague of albino mice infected with nalidixic acid resistant pathogen (Nal(r))].
    Ryzhko IV; Trishina AV; Verkina LM
    Antibiot Khimioter; 2010; 55(11-12):22-4. PubMed ID: 21574421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful Treatment of Human Plague with Oral Ciprofloxacin.
    Apangu T; Griffith K; Abaru J; Candini G; Apio H; Okoth F; Okello R; Kaggwa J; Acayo S; Ezama G; Yockey B; Sexton C; Schriefer M; Mbidde EK; Mead P
    Emerg Infect Dis; 2017 Mar; 23(3):553-5. PubMed ID: 28125398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plazomicin is effective in a non-human primate pneumonic plague model.
    Mega WM; Doyle-Eisele M; Cass RT; Kostrub CF; Sherwood RL; Metz MA; Cirz RT
    Bioorg Med Chem; 2016 Dec; 24(24):6429-6439. PubMed ID: 27614915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Braun lipoprotein (Lpp) contributes to virulence of yersiniae: potential role of Lpp in inducing bubonic and pneumonic plague.
    Sha J; Agar SL; Baze WB; Olano JP; Fadl AA; Erova TE; Wang S; Foltz SM; Suarez G; Motin VL; Chauhan S; Klimpel GR; Peterson JW; Chopra AK
    Infect Immun; 2008 Apr; 76(4):1390-409. PubMed ID: 18227160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A non-invasive in vivo imaging system to study dissemination of bioluminescent Yersinia pestis CO92 in a mouse model of pneumonic plague.
    Sha J; Rosenzweig JA; Kirtley ML; van Lier CJ; Fitts EC; Kozlova EV; Erova TE; Tiner BL; Chopra AK
    Microb Pathog; 2013 Feb; 55():39-50. PubMed ID: 23063826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection Afforded by Fluoroquinolones in Animal Models of Respiratory Infections with Bacillus anthracis, Yersinia pestis, and Francisella tularensis.
    Peterson JW; Moen ST; Healy D; Pawlik JE; Taormina J; Hardcastle J; Thomas JM; Lawrence WS; Ponce C; Chatuev BM; Gnade BT; Foltz SM; Agar SL; Sha J; Klimpel GR; Kirtley ML; Eaves-Pyles T; Chopra AK
    Open Microbiol J; 2010 Jun; 4():34-46. PubMed ID: 21127743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of Heme Oxygenase Expression by Cobalt Protoporphyrin Treatment Prevents Pneumonic Plague Caused by Inhalation of
    Willix JL; Stockton JL; Olson RM; Anderson PE; Anderson DM
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of levofloxacin, lomefloxacin and moxifloxacin vs. other fluoroquinolones in experimental plague due to FI+ and FI- strains of Yersinia pestis in Albino mice].
    Ryzhko IV; Tsuraeva RI; Anisimov BI; Trishina AV
    Antibiot Khimioter; 2009; 54(5-6):37-40. PubMed ID: 20052916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed pneumonic plague and nosocomial MDR-bacterial infection of lung: a rare case report.
    Andrianaivoarimanana V; Bertherat E; Rajaonarison R; Rakotondramaro T; Rogier C; Rajerison M
    BMC Pulm Med; 2018 May; 18(1):92. PubMed ID: 29843675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic treatment of experimental pneumonic plague in mice.
    Byrne WR; Welkos SL; Pitt ML; Davis KJ; Brueckner RP; Ezzell JW; Nelson GO; Vaccaro JR; Battersby LC; Friedlander AM
    Antimicrob Agents Chemother; 1998 Mar; 42(3):675-81. PubMed ID: 9517950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of protective potential of Yersinia pestis outer membrane protein antigens as possible candidates for a new-generation recombinant plague vaccine.
    Erova TE; Rosenzweig JA; Sha J; Suarez G; Sierra JC; Kirtley ML; van Lier CJ; Telepnev MV; Motin VL; Chopra AK
    Clin Vaccine Immunol; 2013 Feb; 20(2):227-38. PubMed ID: 23239803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxycycline or ciprofloxacin prophylaxis and therapy against experimental Yersinia pestis infection in mice.
    Russell P; Eley SM; Bell DL; Manchee RJ; Titball RW
    J Antimicrob Chemother; 1996 Apr; 37(4):769-74. PubMed ID: 8722542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Doxycycline and Ciprofloxacin for Treatment of Pneumonic Tularemia in Cynomolgus Macaques.
    Williams MS
    Clin Infect Dis; 2024 Jan; 78(Suppl 1):S7-S14. PubMed ID: 38294111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.